Izun Pharma Ltd   Report issue

For profit Phase 2
Founded: New York NY United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2012
NCT01427569
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

clopidogrel (plavix) (1 trial)

izn-6d4 (1 trial)

izn-6n4 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophic Vaginitis (Phase 2)

Atrophy (Phase 2)

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 2)

Head and Neck Neoplasms (Phase 2)

Mucositis (Phase 2)

Stomatitis (Phase 2)

Ulcer (Phase 2)

Vaginitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3